HEADER TRANSFERASE 16-JUN-22 8A5X TITLE CRYSTAL STRUCTURE OF PHOSPHATIDYL INOSITOL 4-KINASE II BETA IN COMPLEX TITLE 2 WITH MM1373 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-BETA,ENDOLYSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PHOSPHATIDYLINOSITOL 4-KINASE TYPE II-BETA,PI4KII-BETA,LYSIS COMPND 5 PROTEIN,LYSOZYME,MURAMIDASE; COMPND 6 EC: 2.7.1.67,3.2.1.17,2.7.1.67; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PI4K2B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS LIPID, KINASE, PI4K2B, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.KLIMA,E.BOURA REVDAT 4 31-JAN-24 8A5X 1 REMARK REVDAT 3 19-OCT-22 8A5X 1 JRNL REVDAT 2 12-OCT-22 8A5X 1 JRNL REVDAT 1 05-OCT-22 8A5X 0 JRNL AUTH M.MISEHE,M.KLIMA,M.MATOUSOVA,D.CHALUPSKA,M.DEJMEK,M.SALA, JRNL AUTH 2 H.MERTLIKOVA-KAISEROVA,E.BOURA,R.NENCKA JRNL TITL STRUCTURE-BASED DESIGN AND MODULAR SYNTHESIS OF NOVEL PI4K JRNL TITL 2 CLASS II INHIBITORS BEARING A 4-AMINOQUINAZOLINE SCAFFOLD. JRNL REF BIOORG.MED.CHEM.LETT. V. 76 29010 2022 JRNL REFN ESSN 1464-3405 JRNL PMID 36184029 JRNL DOI 10.1016/J.BMCL.2022.129010 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 20402 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1020 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.6300 - 4.5900 0.90 2756 146 0.1777 0.2056 REMARK 3 2 4.5900 - 3.6400 0.95 2843 150 0.1774 0.2001 REMARK 3 3 3.6400 - 3.1800 0.96 2872 151 0.2224 0.2353 REMARK 3 4 3.1800 - 2.8900 0.95 2864 150 0.2380 0.2285 REMARK 3 5 2.8900 - 2.6800 0.95 2839 150 0.2493 0.2935 REMARK 3 6 2.6800 - 2.5300 0.89 2667 139 0.2593 0.2788 REMARK 3 7 2.5300 - 2.4000 0.85 2541 134 0.2628 0.2942 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.274 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.916 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.31 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3894 REMARK 3 ANGLE : 0.477 5268 REMARK 3 CHIRALITY : 0.040 560 REMARK 3 PLANARITY : 0.004 702 REMARK 3 DIHEDRAL : 10.878 1470 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8A5X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292123717. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54187 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS XDSGUI2 REMARK 200 DATA SCALING SOFTWARE : XDS XDSGUI2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20410 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 31.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.09953 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.60790 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.290 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 4WTV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% W/V PEG 8.000, 20% V/V ETHYLENE REMARK 280 GLYCOL, 3% V/V DMSO, 100 MM BICINE/TRIZMA BASE PH 8.5, 20 MM 1,6- REMARK 280 HEXANEDIOL, 20 MM 1-BUTANOL, 20 MM 1,2-PROPANEDIOL, 20 MM 2- REMARK 280 PROPANOL, 20 MM 1,4-BUTANEDIOL, 20 MM 1,3-PROPANEDIOL, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.50350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 90 REMARK 465 THR A 91 REMARK 465 ILE A 92 REMARK 465 GLY A 93 REMARK 465 THR A 94 REMARK 465 SER A 95 REMARK 465 SER A 227 REMARK 465 ARG A 228 REMARK 465 GLY A 229 REMARK 465 LYS A 230 REMARK 465 LYS A 231 REMARK 465 TYR A 232 REMARK 465 ALA A 233 REMARK 465 LEU A 234 REMARK 465 GLU A 235 REMARK 465 LYS A 236 REMARK 465 VAL A 237 REMARK 465 PRO A 238 REMARK 465 LYS A 239 REMARK 465 VAL A 240 REMARK 465 GLY A 241 REMARK 465 ARG A 242 REMARK 465 LYS A 243 REMARK 465 PHE A 244 REMARK 465 HIS A 245 REMARK 465 ARG A 246 REMARK 465 ILE A 247 REMARK 465 GLU A 315 REMARK 465 LYS A 316 REMARK 465 GLN A 317 REMARK 465 LYS A 318 REMARK 465 CYS A 319 REMARK 465 GLU A 320 REMARK 465 LYS A 321 REMARK 465 GLU A 322 REMARK 465 ILE A 323 REMARK 465 ASP A 324 REMARK 465 HIS A 325 REMARK 465 LYS A 326 REMARK 465 GLU A 327 REMARK 465 SER A 328 REMARK 465 LYS A 329 REMARK 465 TRP A 330 REMARK 465 ILE A 331 REMARK 465 ASP A 332 REMARK 465 ASP A 333 REMARK 465 GLU A 334 REMARK 465 GLU A 335 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 96 CG CD OE1 OE2 REMARK 470 LYS A 407 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 98 30.76 -96.29 REMARK 500 ASP A1019 -169.76 -79.10 REMARK 500 ARG A 177 14.55 56.86 REMARK 500 ASN A 345 48.95 -93.73 REMARK 500 REMARK 500 REMARK: NULL DBREF 8A5X A 90 165 UNP Q8TCG2 P4K2B_HUMAN 90 165 DBREF 8A5X A 1001 1163 UNP P00720 ENLYS_BPT4 2 164 DBREF 8A5X A 176 450 UNP Q8TCG2 P4K2B_HUMAN 176 450 SEQADV 8A5X GLY A 1011 UNP P00720 ARG 12 ENGINEERED MUTATION SEQADV 8A5X THR A 1053 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 8A5X ALA A 1096 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 8A5X ARG A 1136 UNP P00720 ILE 137 ENGINEERED MUTATION SEQRES 1 A 514 VAL THR ILE GLY THR SER GLU MET ASN ALA PHE LEU ASP SEQRES 2 A 514 ASP PRO GLU PHE ALA ASP ILE MET LEU ARG ALA GLU GLN SEQRES 3 A 514 ALA ILE GLU VAL GLY ILE PHE PRO GLU ARG ILE SER GLN SEQRES 4 A 514 GLY SER SER GLY SER TYR PHE VAL LYS ASP PRO LYS ARG SEQRES 5 A 514 LYS ILE ILE GLY VAL PHE LYS PRO LYS SER GLU GLU PRO SEQRES 6 A 514 TYR GLY GLN LEU ASN PRO LYS TRP THR LYS TYR ASN ILE SEQRES 7 A 514 PHE GLU MET LEU ARG ILE ASP GLU GLY LEU ARG LEU LYS SEQRES 8 A 514 ILE TYR LYS ASP THR GLU GLY TYR TYR THR ILE GLY ILE SEQRES 9 A 514 GLY HIS LEU LEU THR LYS SER PRO SER LEU ASN ALA ALA SEQRES 10 A 514 LYS SER GLU LEU ASP LYS ALA ILE GLY ARG ASN THR ASN SEQRES 11 A 514 GLY VAL ILE THR LYS ASP GLU ALA GLU LYS LEU PHE ASN SEQRES 12 A 514 GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE LEU ARG ASN SEQRES 13 A 514 ALA LYS LEU LYS PRO VAL TYR ASP SER LEU ASP ALA VAL SEQRES 14 A 514 ARG ARG ALA ALA LEU ILE ASN MET VAL PHE GLN MET GLY SEQRES 15 A 514 GLU THR GLY VAL ALA GLY PHE THR ASN SER LEU ARG MET SEQRES 16 A 514 LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA VAL ASN LEU SEQRES 17 A 514 ALA LYS SER ARG TRP TYR ASN GLN THR PRO ASN ARG ALA SEQRES 18 A 514 LYS ARG VAL ILE THR THR PHE ARG THR GLY THR TRP ASP SEQRES 19 A 514 ALA TYR LYS ASN LEU GLY ARG GLY CYS LEU ILE PRO ASN SEQRES 20 A 514 GLN GLY TYR LEU SER GLU ALA GLY ALA TYR LEU VAL ASP SEQRES 21 A 514 ASN LYS LEU HIS LEU SER ILE VAL PRO LYS THR LYS VAL SEQRES 22 A 514 VAL TRP LEU VAL SER GLU THR PHE ASN TYR ASN ALA ILE SEQRES 23 A 514 ASP ARG ALA LYS SER ARG GLY LYS LYS TYR ALA LEU GLU SEQRES 24 A 514 LYS VAL PRO LYS VAL GLY ARG LYS PHE HIS ARG ILE GLY SEQRES 25 A 514 LEU PRO PRO LYS ILE GLY SER PHE GLN LEU PHE VAL GLU SEQRES 26 A 514 GLY TYR LYS GLU ALA GLU TYR TRP LEU ARG LYS PHE GLU SEQRES 27 A 514 ALA ASP PRO LEU PRO GLU ASN ILE ARG LYS GLN PHE GLN SEQRES 28 A 514 SER GLN PHE GLU ARG LEU VAL ILE LEU ASP TYR ILE ILE SEQRES 29 A 514 ARG ASN THR ASP ARG GLY ASN ASP ASN TRP LEU VAL ARG SEQRES 30 A 514 TYR GLU LYS GLN LYS CYS GLU LYS GLU ILE ASP HIS LYS SEQRES 31 A 514 GLU SER LYS TRP ILE ASP ASP GLU GLU PHE LEU ILE LYS SEQRES 32 A 514 ILE ALA ALA ILE ASP ASN GLY LEU ALA PHE PRO PHE LYS SEQRES 33 A 514 HIS PRO ASP GLU TRP ARG ALA TYR PRO PHE HIS TRP ALA SEQRES 34 A 514 TRP LEU PRO GLN ALA LYS VAL PRO PHE SER GLU GLU ILE SEQRES 35 A 514 ARG ASN LEU ILE LEU PRO TYR ILE SER ASP MET ASN PHE SEQRES 36 A 514 VAL GLN ASP LEU CYS GLU ASP LEU TYR GLU LEU PHE LYS SEQRES 37 A 514 THR ASP LYS GLY PHE ASP LYS ALA THR PHE GLU SER GLN SEQRES 38 A 514 MET SER VAL MET ARG GLY GLN ILE LEU ASN LEU THR GLN SEQRES 39 A 514 ALA LEU ARG ASP GLY LYS SER PRO PHE GLN LEU VAL GLN SEQRES 40 A 514 ILE PRO CYS VAL ILE VAL GLU HET L6A A2001 22 HETNAM L6A 4-AZANYL-7-[3-(HYDROXYMETHYL)PHENYL]QUINAZOLINE-6- HETNAM 2 L6A CARBOXAMIDE FORMUL 2 L6A C16 H14 N4 O2 FORMUL 3 HOH *106(H2 O) HELIX 1 AA1 ASP A 103 VAL A 119 1 17 HELIX 2 AA2 SER A 151 GLU A 153 5 3 HELIX 3 AA3 LYS A 161 TYR A 165 5 5 HELIX 4 AA4 ASN A 1001 GLU A 1010 1 10 HELIX 5 AA5 SER A 1037 GLY A 1050 1 14 HELIX 6 AA6 THR A 1058 ARG A 1079 1 22 HELIX 7 AA7 LEU A 1083 LEU A 1090 1 8 HELIX 8 AA8 ASP A 1091 GLY A 1112 1 22 HELIX 9 AA9 PHE A 1113 GLN A 1122 1 10 HELIX 10 AB1 ARG A 1124 ALA A 1133 1 10 HELIX 11 AB2 SER A 1135 THR A 1141 1 7 HELIX 12 AB3 THR A 1141 GLY A 1155 1 15 HELIX 13 AB4 TRP A 1157 LYS A 1161 5 5 HELIX 14 AB5 LEU A 1163 CYS A 179 5 5 HELIX 15 AB6 GLN A 184 HIS A 200 1 17 HELIX 16 AB7 ASN A 220 LYS A 226 1 7 HELIX 17 AB8 ALA A 266 ASP A 276 1 11 HELIX 18 AB9 PRO A 279 ARG A 301 1 23 HELIX 19 AC1 PHE A 362 VAL A 372 5 11 HELIX 20 AC2 SER A 375 SER A 387 1 13 HELIX 21 AC3 ASP A 388 LYS A 404 1 17 HELIX 22 AC4 ASP A 410 ASP A 434 1 25 HELIX 23 AC5 SER A 437 VAL A 442 1 6 SHEET 1 AA1 5 GLU A 124 ARG A 125 0 SHEET 2 AA1 5 TYR A 134 LYS A 137 -1 O PHE A 135 N GLU A 124 SHEET 3 AA1 5 ILE A 143 PRO A 149 -1 O PHE A 147 N TYR A 134 SHEET 4 AA1 5 LYS A 252 LEU A 258 -1 O GLN A 257 N VAL A 146 SHEET 5 AA1 5 THR A 207 LEU A 212 -1 N LEU A 212 O LYS A 252 SHEET 1 AA2 3 ARG A1013 LYS A1018 0 SHEET 2 AA2 3 TYR A1024 GLY A1027 -1 O THR A1025 N TYR A1017 SHEET 3 AA2 3 HIS A1030 THR A1033 -1 O LEU A1032 N TYR A1024 SHEET 1 AA3 3 LYS A 264 GLU A 265 0 SHEET 2 AA3 3 TRP A 310 ARG A 313 -1 O VAL A 312 N LYS A 264 SHEET 3 AA3 3 LYS A 339 ALA A 342 -1 O LYS A 339 N ARG A 313 CRYST1 48.383 87.007 71.376 90.00 107.78 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020668 0.000000 0.006628 0.00000 SCALE2 0.000000 0.011493 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014713 0.00000